Cytoreductive radical prostatectomy (cRP) in the management of patients with newly diagnosed metastatic hormone-sensitive prostate cancer (mHSPC).

被引：0
|
作者：
Heidenreich, Axel
Rieger, Constantin
Kastner, Lucas
Seelemeyer, Felix
Pfister, David
机构：
[1] Univ Hosp Cologne, Dept Urol, Cologne, Germany
[2] Univ Clin Cologne, Dept Urol, Cologne, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
161
引用
收藏
页数：1
相关论文
共 50 条
  • [1] The role of cytoreductive radical prostatectomy (cRP) in men with hormone-sensitive, metastatic prostate cancer (mPCA)
    Heidenreich, Axel
    Fossati, Nicola
    Suardi, Nazareno
    Montorsi, Francesco
    Karnes, Jeffrey
    Shariat, Shahrokh F.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
  • [2] Abiraterone plus prednisone in patients with newly diagnosed high-risk metastatic hormone-sensitive prostate cancer (mHSPC)
    Miller, Kurt
    AKTUELLE UROLOGIE, 2019, 50 (06) : 625 - 628
  • [3] Cytoreductive cryotherapy for newly diagnosed oligometastatic hormone-sensitive prostate cancer
    M. J. Connor
    M. Winkler
    H. U. Ahmed
    Prostate Cancer and Prostatic Diseases, 2020, 23 : 537 - 538
  • [4] Cytoreductive cryotherapy for newly diagnosed oligometastatic hormone-sensitive prostate cancer
    Connor, M. J.
    Winkler, M.
    Ahmed, H. U.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2020, 23 (03) : 537 - 538
  • [5] Use of abiraterone for patients with metastatic hormone-sensitive prostate cancer (mHSPC)
    Cathomas, R.
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 130 - 130
  • [6] TITAN study: evaluation of apalutamide in patients with metastatic hormone-sensitive prostate cancer - Treatment of metastatic hormone-sensitive prostate cancer (mHSPC)
    Merseburger, Axel S.
    Suttmann, Henrik
    AKTUELLE UROLOGIE, 2021, 52 (02) : 155 - 160
  • [7] Management of Metastatic Hormone-Sensitive Prostate Cancer (mHSPC): an Evolving Treatment Paradigm
    Weiner, Adam B.
    Nettey, Oluwarotimi S.
    Morgans, Alicia K.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2019, 20 (09)
  • [8] Management of Metastatic Hormone-Sensitive Prostate Cancer (mHSPC): an Evolving Treatment Paradigm
    Adam B. Weiner
    Oluwarotimi S. Nettey
    Alicia K. Morgans
    Current Treatment Options in Oncology, 2019, 20
  • [9] Cytoreductive Radical Prostatectomy for Metastatic Hormone-sensitive Prostate Cancer-Evidence from Recent Prospective Reports
    Rajwa, Pawel
    Zattoni, Fabio
    Maggi, Martina
    Marra, Giancarlo
    Kroyer, Petra
    Shariat, Shahrokh F.
    Briganti, Alberto
    Montorsi, Francesco
    Heidegger, Isabel
    Gandaglia, Giorgio
    EUROPEAN UROLOGY FOCUS, 2023, 9 (04): : 637 - 641
  • [10] Clinical efficacy of cytoreductive radical prostatectomy in the treatment of oligometastatic hormone-sensitive prostate cancer
    Feng Qi
    Yihang Xu
    Zicheng Xu
    Qing Zou
    Holistic Integrative Oncology, 4 (1):
12345